These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24356421)

  • 1. GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
    Yang L; Friedland S; Corson N; Xu L
    Cancer Res; 2014 Feb; 74(4):1022-31. PubMed ID: 24356421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.
    Xu L; Begum S; Hearn JD; Hynes RO
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9023-8. PubMed ID: 16757564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR56 and TG2: possible roles in suppression of tumor growth by the microenvironment.
    Xu L; Hynes RO
    Cell Cycle; 2007 Jan; 6(2):160-5. PubMed ID: 17314516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific and direct modulation of the interaction between adhesion GPCR GPR56/ADGRG1 and tissue transglutaminase 2 using synthetic ligands.
    Salzman GS; Zhang S; Fernandez CG; Araç D; Koide S
    Sci Rep; 2020 Oct; 10(1):16912. PubMed ID: 33037308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
    Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Transglutaminase 2 Activates Epithelial ADAM17: Link to G-Protein-Coupled Receptor 56 (ADGRG1) Signalling.
    Bauer L; Edwards J; Heil A; Dewitt S; Biebermann H; Aeschlimann D; Knäuper V
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Adhesion G-Protein-Coupled Receptor, GPR56/ADGRG1, Inhibits Cell-Extracellular Matrix Signaling to Prevent Metastatic Melanoma Growth.
    Millar MW; Corson N; Xu L
    Front Oncol; 2018; 8():8. PubMed ID: 29450192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
    Stamnaes J; Cardoso I; Iversen R; Sollid LM
    FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR56 in cancer progression: current status and future perspective.
    Yang L; Xu L
    Future Oncol; 2012 Apr; 8(4):431-40. PubMed ID: 22515446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase 2 has higher affinity for relaxed than for stretched fibronectin fibers.
    Selcuk K; Leitner A; Braun L; Le Blanc F; Pacak P; Pot S; Vogel V
    Matrix Biol; 2024 Jan; 125():113-132. PubMed ID: 38135164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.
    Sima LE; Yakubov B; Zhang S; Condello S; Grigorescu AA; Nwani NG; Chen L; Schiltz GE; Arvanitis C; Zhang ZY; Matei D
    Mol Cancer Ther; 2019 Jun; 18(6):1057-1068. PubMed ID: 31015308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
    Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
    FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells.
    Giera S; Luo R; Ying Y; Ackerman SD; Jeong SJ; Stoveken HM; Folts CJ; Welsh CA; Tall GG; Stevens B; Monk KR; Piao X
    Elife; 2018 May; 7():. PubMed ID: 29809138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth.
    Jones RA; Kotsakis P; Johnson TS; Chau DY; Ali S; Melino G; Griffin M
    Cell Death Differ; 2006 Sep; 13(9):1442-53. PubMed ID: 16294209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin interacts with the adhesion GPCR GPR56, reduces receptor shedding, and promotes cell adhesion and motility.
    Chiang NY; Chang GW; Huang YS; Peng YM; Hsiao CC; Kuo ML; Lin HH
    J Cell Sci; 2016 Jun; 129(11):2156-69. PubMed ID: 27068534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?
    van Strien ME; Brevé JJ; Fratantoni S; Schreurs MW; Bol JG; Jongenelen CA; Drukarch B; van Dam AM
    PLoS One; 2011; 6(9):e25037. PubMed ID: 21949843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAIN domain-mediated cleavage is required for activation of G protein-coupled receptor 56 (GPR56) by its natural ligands and a small-molecule agonist.
    Zhu B; Luo R; Jin P; Li T; Oak HC; Giera S; Monk KR; Lak P; Shoichet BK; Piao X
    J Biol Chem; 2019 Dec; 294(50):19246-19254. PubMed ID: 31628191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
    Kotsakis P; Wang Z; Collighan RJ; Griffin M
    Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPR56 Regulates VEGF production and angiogenesis during melanoma progression.
    Yang L; Chen G; Mohanty S; Scott G; Fazal F; Rahman A; Begum S; Hynes RO; Xu L
    Cancer Res; 2011 Aug; 71(16):5558-68. PubMed ID: 21724588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.
    Scarpellini A; Germack R; Lortat-Jacob H; Muramatsu T; Billett E; Johnson T; Verderio EA
    J Biol Chem; 2009 Jul; 284(27):18411-23. PubMed ID: 19398782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.